Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 30, 2026
CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: September 11, 2025
Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy.
Journal: The Lancet. Oncology
Published: April 03, 2025
Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: March 04, 2025
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study.
Journal: Frontiers in oncology
Published: January 05, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: August 04, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.
Journal: NEJM evidence
Published: July 23, 2024
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.
Journal: Clinical breast cancer
Published: June 14, 2024
A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: April 02, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 02, 2024
Last Updated: 09/26/2026